Patrick Schummer
Universitätsklinikum Würzburg(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, Cutaneous lymphoproliferative disorders research, CAR-T cell therapy research, Melanoma and MAPK Pathways
Most-Cited Works
- → Superior skin cancer classification by the combination of human and artificial intelligence(2019)349 cited
- → Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?(2020)40 cited
- → Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG(2022)30 cited
- → Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition(2021)29 cited
- → Specific c-Jun target genes in malignant melanoma(2016)27 cited
- → MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG(2022)12 cited
- → Patient Preferences in Hidradenitis Suppurativa (APProach‐HS): a discrete choice experiment(2022)10 cited
- → Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry(2022)8 cited
- → Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors(2018)8 cited
- → Neoadjuvant ipilimumab plus nivolumab in locally advanced melanoma: A real-world single-centre retrospective study(2023)8 cited